Trials / Completed
CompletedNCT03833102
Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 165 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to demonstrate that the risk of S. aureus bacteremia (SAB) is correlated to the RNA III and SprD RNAs expression
Detailed description
Staphylococcus aureus ranks among the top three organisms for community-acquired, healthcare-related and nosocomial infections in humans. It lives as a commensal organism but can also provoke very severe diseases. Identifying markers of the 'colonization/disease' transition is of paramount importance. We recently found that an association of two regulatory RNAs was associated with S. aureus infection rather than colonization and with the severity of infection. Those preliminary results have to be confirmed with a more important prospective cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biological analysis | ST types will be determined for all individualized bacterial strains. For all the bacterial strains, RNAs expression will be analyzed at three different growth phases: early exponential phase, mid exponential phase and early stationary phase. Expression of RNAIII and SprD will be evaluated by quantitative polymerase chain reaction. |
Timeline
- Start date
- 2018-02-21
- Primary completion
- 2022-11-22
- Completion
- 2023-02-22
- First posted
- 2019-02-06
- Last updated
- 2023-04-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03833102. Inclusion in this directory is not an endorsement.